Abattis Bioceuticals Corp. (ATTBF)

Overview

Abattis Bioceuticals Corp. is a life sciences and biotechnology company based in Canada. It specializes in the development and licensing of natural health products, medicines, extractions, and ingredients, targeting the biological, nutraceutical, bioceutical, and cosmetic markets. Initially known as Abattis Biologix Corporation, the company underwent a rebranding to Abattis Bioceuticals Corporation in September 2012. Founded in 1997, its headquarters are situated in Vancouver, Canada. Abattis plays a vital role in the cannabinoid industry by offering enhanced nutraceuticals for pain and inflammation, as well as Health-Canada licensed services for the cannabis sector.

Products and Services

Comfort: A flagship product of Abattis, Comfort is a cannabinoid-enhanced nutraceutical designed to target pain and inflammation. This product reflects the company's focus on integrating the therapeutic potentials of cannabinoids into conventional health products, offering a natural alternative for pain management.

Health-Canada Licensed Services: Abattis provides specialized services for the cannabis industry, facilitated by its licensing under Health Canada. These services span across quality control, cultivation, extraction, and product development, catering to the rigorous compliance and product innovation needs of the cannabis market. This avenue not only underscores the company's expertise in regulatory navigation but also positions it as a key player in supporting the burgeoning cannabis industry in Canada.